Treace Medical Concepts, Inc. Common Stock
$4.53
-$0.03 (-0.66%)
$4.47Day Range$4.66
Key Statistics
Market Cap
$294.61M
Shares Outstanding
65.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 23, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$4.66
Day High
$4.66
Day Low
$4.47
Volume
196.7K
VWAP
$4.54
Prev Close
$4.56
Transactions
--
Acc. Volume
--
About Treace Medical Concepts, Inc. Common Stock
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841450 employees100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081(904) 373-5940IPO Apr 23, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001630627
- Composite FIGI
- BBG00GQKR6M4
- Share Class FIGI
- BBG00GQKR6N3
- Ticker Root
- TMCI
- SIC Code
- 3841
About Treace Medical Concepts, Inc. Common Stock (TMCI) Stock
Treace Medical Concepts, Inc. Common Stock (TMCI) closed the 2026-09-17 session at $4.53, down 0.66% versus the previous close (-0.03). The stock opened at $4.66 and traded between $4.47 and $4.66 during that session. Session trading volume was 197K shares. The volume-weighted average price (VWAP) is $4.54.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
Treace Medical Concepts, Inc. Common Stock has a market capitalization of $294.6 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. TMCI is listed on the XNAS exchange. The company employs approximately 450 people. Treace Medical Concepts, Inc. Common Stock is headquartered in PONTE VEDRA, FL. The recorded listing date is 2021-04-23.
On this page you can find market TMCI stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.